Switzerland

Roche reports positive data for experimental eye-disease treatment

Roche has reported positive 52-week results for vamikibart, an experimental treatment for vision loss linked to uveitis. The drug improved vision and reduced retinal swelling in two Phase III trials, but has not yet been approved.